Hogan Lovells advises Shop Apotheke Europe N.V. on placement of EUR 225 million convertible bonds

The bonds do not bear interest. The initial conversion price was set at EUR 233.83, this represents a premium of 50.0 per cent to the volume-weighted average share price during the bookbuilding process on January 14, 2021. The Company intends to use the proceeds from the offering for general corporate purposes. The convertible bonds are expected to be included promptly in trading on the Open Market of the Frankfurt Stock Exchange.

Goldman Sachs Bank Europe SE acted as Sole Global Coordinator and Sole Bookrunner for the issuance and placement.

Hogan Lovells team for Shop Apotheke Europe N.V. 

Frankfurt

Prof. Dr. Michael Schlitt (Partner), Dr. Susanne Ries (Of Counsel), Mark Devlin (Counsel), Dr. Timo Lockemann, Christian Schröder (Associates), Eva-Christina Sommer, Simona Gradišek (Business Lawyers) (all Capital Markets);

Dusseldorf

Dr. Heiko Gemmel (Partner), Anne-Svenja de Kiff (Counsel) (all Tax);

Amsterdam

Victor de Vlaam (Partner), Aafke Pronk (Counsel), Leonie Huisman (Counsel), Janelle de Ruiter, Georgi Yavorov Boyadzhiev (Associates) (all Corporate);

Alexander Fortuin (Partner, Tax);

London

Jonathan Baird (Partner, US Law, London).

Inhouse Shop Apotheke Europe N.V.: Rens Jan Kramer, Alain Probst